Erschienen in:
01.07.2010 | Adis Profile Report
Escitalopram in the treatment of major depressive disorder in adolescent patients
Profile report
verfasst von:
Lily P. H. Yang, Lesley J. Scott
Erschienen in:
CNS Drugs
|
Ausgabe 7/2010
Einloggen, um Zugang zu erhalten
Excerpt
Depression is a recurrent and highly heterogeneous psychiatric disorder that impacts on social, emotional and cognitive functioning.[
2,
3] More specifically, major depressive disorder (MDD) is characterized by a mood change to sadness or irritability, and is accompanied by other changes such as sleep or appetite disturbances, with suicidality as one of the main complications.[
2‐
4] The estimated prevalence of MDD is ≈2% in children and 4–8% in adolescents.[
2] …